BIM
MRNS

BlackRock Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
506
– – ﹤0.01% 3890
2016
Q3 		$4K Hold
506
– – ﹤0.01% 3819
2016
Q2 		$3K Buy
506
+245
+94% +$4.51K ﹤0.01% 3938
2016
Q1 		$6K Buy
261
+42
+19% +$890 ﹤0.01% 3783
2015
Q4 		$7K Buy
219
+25
+13% +$733 ﹤0.01% 3794
2015
Q3 		$6K Hold
194
– – ﹤0.01% 3884
2015
Q2 		$9K Sell
194
-53
-21% -$1.98K ﹤0.01% 3776
2015
Q1 		$9K Buy
247
+23
+10% +$1.01K ﹤0.01% 3702
2014
Q4 		$9K Hold
224
– – ﹤0.01% 3721
2014
Q3 		$6K Buy
+224
New +$6.92K ﹤0.01% 3860

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

BlackRock Investment Management's MRNS Position: Q4 2016 in Review

BlackRock Investment Management held its Marinus Pharmaceuticals, Inc (MRNS) position steady in Q4 2016 at 506 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3890.

BlackRock Investment Management first reported a position in MRNS in Q3 2014 and has held it in 10 quarters since. The position peaked at $9K in Q2 2015. 23 funds tracked by Wall St. Rank hold MRNS as of Q4 2016.

  • BlackRock Investment Management held 506 shares of Marinus Pharmaceuticals, Inc worth $2K as of Q4 2016.
  • BlackRock Investment Management left its Marinus Pharmaceuticals, Inc share count unchanged in Q4 2016.
  • Marinus Pharmaceuticals, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3890 holding.
  • BlackRock Investment Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Investment Management's Marinus Pharmaceuticals, Inc position peaked at $9K in Q2 2015.
  • 23 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.